WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel-Reference-Cited by-同舟云学术

WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel

Published:2017-03-27 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Artibani Mara,Sims Andrew H.,Slight Joan,Aitken Stuart,Thornburn Anna,Muir Morwenna,Brunton Valerie G.,Del-Pozo Jorge,Morrison Linda R.,Katz Elad,Hastie Nicholas D.,Hohenstein Peter

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep45255.pdf

Reference70 articles.

1. Hohenstein, P. & Hastie, N. D. The many facets of the Wilms’ tumour gene, WT1. Human molecular genetics 15 Spec No 2, R196–201, doi: 10.1093/hmg/ddl196 (2006).

2. Martinez-Estrada, O. M. et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nature genetics 42, 89–93, doi: 10.1038/ng.494 (2010).

3. Essafi, A. et al. A wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression. Developmental cell 21, 559–574, doi: 10.1016/j.devcel.2011.07.014 (2011).

4. Chau, Y. Y. & Hastie, N. D. The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. Trends in genetics: TIG 28, 515–524, doi: 10.1016/j.tig.2012.04.004 (2012).

5. Silberstein, G. B., Van Horn, K., Strickland, P., Roberts, C. T. & Daniel, C. W. Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America 94, 8132–8137 (1997).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologically informed NeuralODEs for genome-wide regulatory dynamics;Genome Biology;2024-05-21

2. Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms;Molecular Biology Reports;2024-04-20

3. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors;Cancer Research;2024-04-08

4. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin;American Journal of Surgical Pathology;2024-02-15

5. LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer;Journal of Cancer;2024